25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CMPD (Compumed) Stock Analysis
Buy, Hold or Sell?

Let's analyze Compumed together

I guess you are interested in CompuMed Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Compumed’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Compumed’s Price Targets

I'm going to help you getting a better view of CompuMed Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CompuMed Inc

I send you an email if I find something interesting about CompuMed Inc.

1. Quick Overview

1.1. Quick analysis of Compumed (30 sec.)










1.2. What can you expect buying and holding a share of Compumed? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.49
Expected worth in 1 year
$4.50
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$2.01
Return On Investment
60.9%

For what price can you sell your share?

Current Price per Share
$3.30
Expected price per share
$2.75 - $4.67
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Compumed (5 min.)




Live pricePrice per Share (EOD)
$3.30
Intrinsic Value Per Share
$-0.35 - $2.74
Total Value Per Share
$2.13 - $5.22

2.2. Growth of Compumed (5 min.)




Is Compumed growing?

Current yearPrevious yearGrowGrow %
How rich?$3.2m$3m$192.6k5.9%

How much money is Compumed making?

Current yearPrevious yearGrowGrow %
Making money$192.6k-$32.6k$225.2k116.9%
Net Profit Margin3.1%-0.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Compumed (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Compumed?

Welcome investor! Compumed's management wants to use your money to grow the business. In return you get a share of Compumed.

First you should know what it really means to hold a share of Compumed. And how you can make/lose money.

Speculation

The Price per Share of Compumed is $3.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Compumed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Compumed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.49. Based on the TTM, the Book Value Change Per Share is $0.50 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Compumed.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.154.4%0.154.4%-0.02-0.6%0.144.3%0.278.3%0.237.0%
Usd Book Value Change Per Share0.5015.2%0.5015.2%-0.31-9.5%0.103.0%0.226.6%0.247.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.5015.2%0.5015.2%-0.31-9.5%0.103.0%0.226.6%0.247.3%
Usd Price Per Share3.63-3.63-3.17-3.60-2.27-1.19-
Price to Earnings Ratio24.88-24.88--151.48--37.75--22.38--10.90-
Price-to-Total Gains Ratio7.22-7.22--10.16-11.09-6.94-4.39-
Price to Book Ratio1.46-1.46-1.60-1.60-1.02-0.63-
Price-to-Total Gains Ratio7.22-7.22--10.16-11.09-6.94-4.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.3
Number of shares303
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.500.22
Usd Total Gains Per Share0.500.22
Gains per Quarter (303 shares)152.3365.81
Gains per Year (303 shares)609.31263.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106095990263253
20121912080527516
30182818170790779
4024372426010531042
5030473035013161305
6036563644015801568
7042654253018431831
8048754862021062094
9054845471023692357
10060936080026332620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%8.024.00.025.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%19.013.00.059.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.031.03.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%19.013.00.059.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CompuMed Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5030.5030%-0.312+162%0.100+401%0.217+131%0.240+110%
Book Value Per Share--2.4872.4870%1.985+25%2.256+10%2.136+16%1.350+84%
Current Ratio--2.9132.9130%2.184+33%2.578+13%2.687+8%2.245+30%
Debt To Asset Ratio--0.2890.2890%0.303-5%0.291-1%0.332-13%0.413-30%
Debt To Equity Ratio--0.4070.4070%0.435-6%0.410-1%0.512-20%0.786-48%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--5019864.2005019864.2000%4672744.280+7%5565872.160-10%3606278.074+39%1752435.062+186%
Eps--0.1460.1460%-0.021+114%0.141+3%0.275-47%0.230-36%
Ev To Ebitda Ratio--5.2735.2730%6.770-22%6.102-14%3.903+35%2.005+163%
Ev To Sales Ratio--0.8070.8070%0.800+1%0.903-11%0.586+38%0.265+205%
Free Cash Flow Per Share--0.2690.2690%0.096+179%0.087+208%0.163+65%0.143+87%
Free Cash Flow To Equity Per Share--0.3670.3670%-0.462+226%-0.114+131%0.084+337%0.123+198%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.735----------
Intrinsic Value_10Y_min---0.352----------
Intrinsic Value_1Y_max--0.188----------
Intrinsic Value_1Y_min--0.057----------
Intrinsic Value_3Y_max--0.630----------
Intrinsic Value_3Y_min--0.092----------
Intrinsic Value_5Y_max--1.151----------
Intrinsic Value_5Y_min--0.041----------
Market Cap4357782.000-10%4793560.2004793560.2000%4938809.280-3%5478757.827-13%3452226.874+39%1796603.862+167%
Net Profit Margin--0.0310.0310%-0.006+118%0.035-11%0.067-54%0.060-48%
Operating Margin--0.0380.0380%0.002+1739%0.042-10%0.076-50%0.068-44%
Operating Ratio--0.9670.9670%1.005-4%0.962+1%0.930+4%0.891+9%
Pb Ratio1.327-10%1.4591.4590%1.597-9%1.600-9%1.016+44%0.626+133%
Pe Ratio22.619-10%24.88124.8810%-151.479+709%-37.746+252%-22.384+190%-10.903+144%
Price Per Share3.300-10%3.6303.6300%3.170+15%3.600+1%2.273+60%1.190+205%
Price To Free Cash Flow Ratio12.274-10%13.50213.5020%32.903-59%2.571+425%1.948+593%1.576+757%
Price To Total Gains Ratio6.564-10%7.2217.2210%-10.163+241%11.090-35%6.937+4%4.389+65%
Quick Ratio--2.5162.5160%1.673+50%2.188+15%2.379+6%1.981+27%
Return On Assets--0.0420.0420%-0.007+118%0.043-2%0.084-50%0.086-52%
Return On Equity--0.0590.0590%-0.011+118%0.060-1%0.129-54%0.146-60%
Total Gains Per Share--0.5030.5030%-0.312+162%0.100+401%0.217+131%0.240+110%
Usd Book Value--3284563.0003284563.0000%3091904.000+6%3408436.667-4%3173063.400+4%1958627.900+68%
Usd Book Value Change Per Share--0.5030.5030%-0.312+162%0.100+401%0.217+131%0.240+110%
Usd Book Value Per Share--2.4872.4870%1.985+25%2.256+10%2.136+16%1.350+84%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--5019864.2005019864.2000%4672744.280+7%5565872.160-10%3606278.074+39%1752435.062+186%
Usd Eps--0.1460.1460%-0.021+114%0.141+3%0.275-47%0.230-36%
Usd Free Cash Flow--355030.000355030.0000%150100.000+137%110623.000+221%228163.600+56%195685.000+81%
Usd Free Cash Flow Per Share--0.2690.2690%0.096+179%0.087+208%0.163+65%0.143+87%
Usd Free Cash Flow To Equity Per Share--0.3670.3670%-0.462+226%-0.114+131%0.084+337%0.123+198%
Usd Market Cap4357782.000-10%4793560.2004793560.2000%4938809.280-3%5478757.827-13%3452226.874+39%1796603.862+167%
Usd Price Per Share3.300-10%3.6303.6300%3.170+15%3.600+1%2.273+60%1.190+205%
Usd Profit--192659.000192659.0000%-32604.000+117%220635.333-13%413498.800-53%328506.900-41%
Usd Revenue--6222018.0006222018.0000%5838109.000+7%6141797.000+1%6002133.000+4%4525505.200+37%
Usd Total Gains Per Share--0.5030.5030%-0.312+162%0.100+401%0.217+131%0.240+110%
 EOD+4 -4MRQTTM+0 -0YOY+32 -53Y+20 -175Y+25 -1210Y+25 -12

3.3 Fundamental Score

Let's check the fundamental score of CompuMed Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.619
Price to Book Ratio (EOD)Between0-11.327
Net Profit Margin (MRQ)Greater than00.031
Operating Margin (MRQ)Greater than00.038
Quick Ratio (MRQ)Greater than12.516
Current Ratio (MRQ)Greater than12.913
Debt to Asset Ratio (MRQ)Less than10.289
Debt to Equity Ratio (MRQ)Less than10.407
Return on Equity (MRQ)Greater than0.150.059
Return on Assets (MRQ)Greater than0.050.042
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of CompuMed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.203
Ma 20Greater thanMa 503.605
Ma 50Greater thanMa 1003.535
Ma 100Greater thanMa 2003.505
OpenGreater thanClose3.300
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About CompuMed Inc

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Fundamental data was last updated by Penke on 2025-06-28 19:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Compumed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Compumed to theΒ Health Information Services industry mean.
  • A Net Profit Margin of 3.1%Β means thatΒ $0.03 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CompuMed Inc:

  • The MRQ is 3.1%. The company is making a profit. +1
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY-0.6%+3.7%
TTM3.1%5Y6.7%-3.7%
5Y6.7%10Y6.0%+0.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%-10.0%+13.1%
TTM3.1%-16.3%+19.4%
YOY-0.6%-12.4%+11.8%
3Y3.5%-23.4%+26.9%
5Y6.7%-20.4%+27.1%
10Y6.0%-30.3%+36.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Compumed is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Compumed to theΒ Health Information Services industry mean.
  • 4.2% Return on Assets means thatΒ Compumed generatedΒ $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CompuMed Inc:

  • The MRQ is 4.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.2%0.0%
TTM4.2%YOY-0.7%+4.9%
TTM4.2%5Y8.4%-4.2%
5Y8.4%10Y8.6%-0.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2%-2.7%+6.9%
TTM4.2%-4.4%+8.6%
YOY-0.7%-3.7%+3.0%
3Y4.3%-5.6%+9.9%
5Y8.4%-5.0%+13.4%
10Y8.6%-5.5%+14.1%
4.3.1.3. Return on Equity

Shows how efficient Compumed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Compumed to theΒ Health Information Services industry mean.
  • 5.9% Return on Equity means Compumed generated $0.06Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CompuMed Inc:

  • The MRQ is 5.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.9%0.0%
TTM5.9%YOY-1.1%+6.9%
TTM5.9%5Y12.9%-7.0%
5Y12.9%10Y14.6%-1.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%-1.7%+7.6%
TTM5.9%-3.2%+9.1%
YOY-1.1%-3.2%+2.1%
3Y6.0%-6.7%+12.7%
5Y12.9%-8.0%+20.9%
10Y14.6%-9.5%+24.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CompuMed Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Compumed is operatingΒ .

  • Measures how much profit Compumed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Compumed to theΒ Health Information Services industry mean.
  • An Operating Margin of 3.8%Β means the company generated $0.04 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CompuMed Inc:

  • The MRQ is 3.8%. The company is operating less efficient.
  • The TTM is 3.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY0.2%+3.6%
TTM3.8%5Y7.6%-3.8%
5Y7.6%10Y6.8%+0.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%-14.2%+18.0%
TTM3.8%-11.5%+15.3%
YOY0.2%-9.5%+9.7%
3Y4.2%-12.5%+16.7%
5Y7.6%-10.6%+18.2%
10Y6.8%-24.8%+31.6%
4.3.2.2. Operating Ratio

Measures how efficient Compumed is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Health Information Services industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CompuMed Inc:

  • The MRQ is 0.967. The company is less efficient in keeping operating costs low.
  • The TTM is 0.967. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.967TTM0.9670.000
TTM0.967YOY1.005-0.038
TTM0.9675Y0.930+0.037
5Y0.93010Y0.891+0.039
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9671.326-0.359
TTM0.9671.334-0.367
YOY1.0051.343-0.338
3Y0.9621.348-0.386
5Y0.9301.342-0.412
10Y0.8911.304-0.413
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CompuMed Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Compumed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Health Information Services industry mean).
  • A Current Ratio of 2.91Β means the company has $2.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CompuMed Inc:

  • The MRQ is 2.913. The company is able to pay all its short-term debts. +1
  • The TTM is 2.913. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.913TTM2.9130.000
TTM2.913YOY2.184+0.729
TTM2.9135Y2.687+0.226
5Y2.68710Y2.245+0.442
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9131.682+1.231
TTM2.9131.562+1.351
YOY2.1841.806+0.378
3Y2.5781.960+0.618
5Y2.6872.666+0.021
10Y2.2452.526-0.281
4.4.3.2. Quick Ratio

Measures if Compumed is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Compumed to theΒ Health Information Services industry mean.
  • A Quick Ratio of 2.52Β means the company can pay off $2.52 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CompuMed Inc:

  • The MRQ is 2.516. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.516. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.516TTM2.5160.000
TTM2.516YOY1.673+0.842
TTM2.5165Y2.379+0.136
5Y2.37910Y1.981+0.398
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5161.037+1.479
TTM2.5161.061+1.455
YOY1.6731.276+0.397
3Y2.1881.445+0.743
5Y2.3792.069+0.310
10Y1.9812.129-0.148
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CompuMed Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of CompumedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Compumed to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.29Β means that Compumed assets areΒ financed with 28.9% credit (debt) and the remaining percentage (100% - 28.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of CompuMed Inc:

  • The MRQ is 0.289. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.289. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.2890.000
TTM0.289YOY0.303-0.014
TTM0.2895Y0.332-0.043
5Y0.33210Y0.413-0.080
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.409-0.120
TTM0.2890.406-0.117
YOY0.3030.375-0.072
3Y0.2910.395-0.104
5Y0.3320.400-0.068
10Y0.4130.405+0.008
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Compumed is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Compumed to theΒ Health Information Services industry mean.
  • A Debt to Equity ratio of 40.7% means that company has $0.41 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CompuMed Inc:

  • The MRQ is 0.407. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.407. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.407TTM0.4070.000
TTM0.407YOY0.435-0.028
TTM0.4075Y0.512-0.104
5Y0.51210Y0.786-0.275
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4070.609-0.202
TTM0.4070.608-0.201
YOY0.4350.571-0.136
3Y0.4100.610-0.200
5Y0.5120.629-0.117
10Y0.7860.636+0.150
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Compumed generates.

  • Above 15 is considered overpriced butΒ always compareΒ Compumed to theΒ Health Information Services industry mean.
  • A PE ratio of 24.88 means the investor is paying $24.88Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CompuMed Inc:

  • The EOD is 22.619. Based on the earnings, the company is fair priced.
  • The MRQ is 24.881. Based on the earnings, the company is fair priced.
  • The TTM is 24.881. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.619MRQ24.881-2.262
MRQ24.881TTM24.8810.000
TTM24.881YOY-151.479+176.360
TTM24.8815Y-22.384+47.265
5Y-22.38410Y-10.903-11.481
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD22.619-1.386+24.005
MRQ24.881-1.651+26.532
TTM24.881-1.178+26.059
YOY-151.479-1.951-149.528
3Y-37.746-2.941-34.805
5Y-22.384-3.176-19.208
10Y-10.903-2.268-8.635
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CompuMed Inc:

  • The EOD is 12.274. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.502. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.502. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.274MRQ13.502-1.227
MRQ13.502TTM13.5020.000
TTM13.502YOY32.903-19.402
TTM13.5025Y1.948+11.553
5Y1.94810Y1.576+0.373
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD12.274-0.381+12.655
MRQ13.502-0.527+14.029
TTM13.502-1.238+14.740
YOY32.903-1.936+34.839
3Y2.571-4.509+7.080
5Y1.948-6.383+8.331
10Y1.576-4.202+5.778
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Compumed is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Health Information Services industry mean).
  • A PB ratio of 1.46 means the investor is paying $1.46Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CompuMed Inc:

  • The EOD is 1.327. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.459. Based on the equity, the company is underpriced. +1
  • The TTM is 1.459. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.327MRQ1.459-0.133
MRQ1.459TTM1.4590.000
TTM1.459YOY1.597-0.138
TTM1.4595Y1.016+0.443
5Y1.01610Y0.626+0.390
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.3271.821-0.494
MRQ1.4591.731-0.272
TTM1.4591.754-0.295
YOY1.5972.524-0.927
3Y1.6002.550-0.950
5Y1.0163.440-2.424
10Y0.6264.256-3.630
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. All numbers in thousands.

Summary
Total Assets4,622
Total Liabilities1,337
Total Stockholder Equity3,285
 As reported
Total Liabilities 1,337
Total Stockholder Equity+ 3,285
Total Assets = 4,622

Assets

Total Assets4,622
Total Current Assets2,957
Long-term Assets1,665
Total Current Assets
Cash And Cash Equivalents 1,564
Net Receivables 990
Inventory 226
Other Current Assets 178
Total Current Assets  (as reported)2,957
Total Current Assets  (calculated)2,957
+/-0
Long-term Assets
Property Plant Equipment 1,180
Intangible Assets 478
Long-term Assets Other 6
Long-term Assets  (as reported)1,665
Long-term Assets  (calculated)1,665
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,015
Long-term Liabilities322
Total Stockholder Equity3,285
Total Current Liabilities
Short-term Debt 200
Accounts payable 267
Other Current Liabilities 548
Total Current Liabilities  (as reported)1,015
Total Current Liabilities  (calculated)1,015
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)322
Long-term Liabilities  (calculated)0
+/- 322
Total Stockholder Equity
Common Stock417
Retained Earnings -33,891
Other Stockholders Equity 36,759
Total Stockholder Equity (as reported)3,285
Total Stockholder Equity (calculated)3,285
+/-0
Other
Cash and Short Term Investments 1,564
Common Stock Shares Outstanding 1,317
Liabilities and Stockholders Equity 4,622
Net Debt -1,041
Net Working Capital 1,942
Short Long Term Debt Total 523



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-302003-09-302002-09-302001-09-302000-09-301999-09-301998-09-301997-09-301996-09-301995-09-301994-09-301993-09-301992-09-301991-09-301990-09-30
> Total Assets 
3,700
4,600
3,800
2,300
6,900
10,500
4,000
1,800
3,500
3,800
3,136
1,679
1,067
780
813
1,273
1,204
2,261
1,310
1,007
741
596
910
623
835
1,520
2,908
4,100
5,134
5,347
4,437
4,622
4,6224,4375,3475,1344,1002,9081,5208356239105967411,0071,3102,2611,2041,2738137801,0671,6793,1363,8003,5001,8004,00010,5006,9002,3003,8004,6003,700
   > Total Current Assets 
1,600
2,900
2,600
1,400
800
6,100
3,300
1,300
3,100
3,200
2,149
993
609
512
593
943
869
1,835
746
536
348
350
511
402
636
1,068
2,193
2,827
3,333
3,167
2,579
2,957
2,9572,5793,1673,3332,8272,1931,0686364025113503485367461,8358699435935126099932,1493,2003,1001,3003,3006,1008001,4002,6002,9001,600
       Cash And Cash Equivalents 
100
1,000
900
0
0
300
200
100
100
2,600
129
239
78
66
62
281
193
969
269
97
58
50
118
126
253
300
1,185
1,890
2,213
1,799
1,079
1,564
1,5641,0791,7992,2131,8901,1853002531261185058972699691932816266782391292,600100100200300009001,000100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
1,554
424
249
181
165
290
385
494
137
111
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001111374943852901651812494241,5540000000000
       Net Receivables 
1,200
1,500
1,300
1,000
500
900
400
200
200
500
275
224
227
219
297
323
253
312
287
293
259
269
307
250
316
674
835
792
854
1,056
897
990
9908971,0568547928356743162503072692592932873122533232972192272242755002002004009005001,0001,3001,5001,200
       Inventory 
300
300
300
300
200
100
100
100
0
100
180
83
41
25
31
31
22
42
35
18
18
19
62
16
48
62
101
37
155
135
400
226
226400135155371016248166219181835422231312541831801000100100100200300300300300
   > Long-term Assets 
2,100
1,700
1,200
900
6,100
4,400
700
500
400
600
987
686
458
268
220
330
335
426
564
471
393
246
0
221
199
452
715
1,273
1,801
2,180
1,858
1,665
1,6651,8582,1801,8011,27371545219922102463934715644263353302202684586869876004005007004,4006,1009001,2001,7002,100
       Property Plant Equipment 
500
500
500
400
5,500
4,000
500
400
300
500
943
658
430
207
142
240
208
275
422
329
245
106
283
217
199
448
707
1,267
1,796
1,359
1,171
1,180
1,1801,1711,3591,7961,2677074481992172831062453294222752082401422074306589435003004005004,0005,500400500500500
       Intangible Assets 
0
0
0
300
300
200
200
100
0
0
0
0
0
50
66
77
114
138
124
127
129
121
90
0
0
0
0
0
0
0
682
478
47868200000009012112912712413811477665000000100200200300300000
       Long-term Assets Other 
1,600
1,200
700
200
300
200
0
0
100
100
44
28
28
11
12
13
13
13
18
15
19
19
0
4
0
4
9
6
4
821
4
6
648214694040191915181313131211282844100100002003002007001,2001,600
> Total Liabilities 
1,100
1,300
1,000
1,300
5,000
5,300
1,000
900
700
900
886
330
250
271
295
466
376
621
597
451
409
480
604
305
404
705
1,058
1,821
1,773
1,498
1,345
1,337
1,3371,3451,4981,7731,8211,0587054043056044804094515976213764662952712503308869007009001,0005,3005,0001,3001,0001,3001,100
   > Total Current Liabilities 
1,100
1,100
900
1,200
1,200
2,200
900
800
500
700
824
315
243
271
256
340
260
488
506
343
338
346
466
294
379
679
664
942
1,234
1,201
1,181
1,015
1,0151,1811,2011,2349426646793792944663463383435064882603402562712433158247005008009002,2001,2001,2009001,1001,100
       Short-term Debt 
300
300
300
500
300
700
0
100
100
200
127
47
8
7
8
33
45
73
88
70
59
56
115
28
22
21
115
215
227
242
229
200
20022924222721511521222811556597088734533878471272001001000700300500300300300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179
178
130
190
115
28
22
0
0
0
0
0
0
0
00000002228115190130178179000000000000000000
       Accounts payable 
300
200
200
300
300
500
300
200
100
300
441
174
119
125
160
159
64
236
258
153
177
209
351
133
152
300
202
190
258
433
425
267
26742543325819020230015213335120917715325823664159160125119174441300100200300500300300200200300
       Other Current Liabilities 
500
600
400
400
600
1,000
600
500
300
200
256
94
116
139
88
148
151
177
158
118
100
79
0
133
205
359
347
536
750
526
527
548
54852752675053634735920513307910011815817715114888139116942562003005006001,000600400400600500
   > Long-term Liabilities 
600
200
100
100
3,800
3,100
100
100
200
200
62
15
7
132
39
126
116
133
91
108
71
134
0
11
25
26
394
879
538
296
164
322
3221642965388793942625110134711089113311612639132715622002001001003,1003,800100100200600
> Total Stockholder Equity
2,600
3,300
2,800
1,000
1,900
5,200
3,000
900
2,800
2,900
2,250
1,349
817
509
518
807
828
1,640
713
556
332
116
306
318
431
815
1,850
2,279
3,361
3,849
3,092
3,285
3,2853,0923,8493,3612,2791,8508154313183061163325567131,6408288075185098171,3492,2502,9002,8009003,0005,2001,9001,0002,8003,3002,600
   Common Stock
0
0
0
0
0
0
0
0
0
200
179
179
179
180
197
230
243
250
260
262
274
279
305
316
316
324
324
322
405
420
417
417
417417420405322324324316316305279274262260250243230197180179179179200000000000
   Retained Earnings -33,891-34,084-34,051-34,538-35,605-35,943-36,917-37,115-37,200-37,066-36,885-36,622-36,204-35,911-34,393-33,013-32,589-32,253-31,978-31,603-31,109-30,212-28,800-27,700-26,400-24,200-19,500-16,100-12,300-10,000-7,900-7,300
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
9,900
11,200
12,800
13,300
18,000
24,700
27,200
27,300
29,600
31,500
32,235
32,241
32,241
32,296
32,520
33,154
33,618
35,842
36,363
36,497
36,679
36,721
0
37,517
37,545
37,732
37,793
37,883
37,493
37,479
36,759
36,759
36,75936,75937,47937,49337,88337,79337,73237,54537,517036,72136,67936,49736,36335,84233,61833,15432,52032,29632,24132,24132,23531,50029,60027,30027,20024,70018,00013,30012,80011,2009,900



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,222
Cost of Revenue-3,197
Gross Profit3,0253,025
 
Operating Income (+$)
Gross Profit3,025
Operating Expense-2,820
Operating Income205205
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,8200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-38
Other Finance Cost-38
Net Interest Income0
 
Pretax Income (+$)
Operating Income205
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)197213
EBIT - interestExpense = 197
197
231
Interest Expense38
Earnings Before Interest and Taxes (EBIT)235235
Earnings Before Interest and Taxes (EBITDA)952
 
After tax Income (+$)
Income Before Tax197
Tax Provision-0
Net Income From Continuing Ops0197
Net Income193
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,017
Total Other Income/Expenses Net-80
 

Technical Analysis of Compumed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Compumed. The general trend of Compumed is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Compumed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Compumed Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CompuMed Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4 < 4.5 < 4.67.

The bearish price targets are: 3.01 > 3.01 > 2.75.

Know someone who trades $CMPD? Share this with them.πŸ‘‡

CompuMed Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CompuMed Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CompuMed Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CompuMed Inc. The current macd is -0.05605776.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Compumed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Compumed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Compumed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CompuMed Inc Daily Moving Average Convergence/Divergence (MACD) ChartCompuMed Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CompuMed Inc. The current adx is 22.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Compumed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
CompuMed Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CompuMed Inc. The current sar is 4.67844788.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CompuMed Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CompuMed Inc. The current rsi is 44.20. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
CompuMed Inc Daily Relative Strength Index (RSI) ChartCompuMed Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CompuMed Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Compumed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CompuMed Inc Daily Stochastic Oscillator ChartCompuMed Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CompuMed Inc. The current cci is -76.45072848.

CompuMed Inc Daily Commodity Channel Index (CCI) ChartCompuMed Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CompuMed Inc. The current cmo is -18.98656085.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CompuMed Inc Daily Chande Momentum Oscillator (CMO) ChartCompuMed Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CompuMed Inc. The current willr is -70.70707071.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Compumed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CompuMed Inc Daily Williams %R ChartCompuMed Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of CompuMed Inc.

CompuMed Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CompuMed Inc. The current atr is 0.29868787.

CompuMed Inc Daily Average True Range (ATR) ChartCompuMed Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CompuMed Inc. The current obv is 68,585.

CompuMed Inc Daily On-Balance Volume (OBV) ChartCompuMed Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CompuMed Inc. The current mfi is 3.84671215.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
CompuMed Inc Daily Money Flow Index (MFI) ChartCompuMed Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CompuMed Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

CompuMed Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CompuMed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.203
Ma 20Greater thanMa 503.605
Ma 50Greater thanMa 1003.535
Ma 100Greater thanMa 2003.505
OpenGreater thanClose3.300
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Compumed with someone you think should read this too:
  • Are you bullish or bearish on Compumed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Compumed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CompuMed Inc

I send you an email if I find something interesting about CompuMed Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CompuMed Inc.

Receive notifications about CompuMed Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.